PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $64,935 | -5.7% | 24,690 | +26.6% | 0.00% | -33.3% |
Q2 2023 | $68,835 | -36.2% | 19,500 | -44.1% | 0.00% | -25.0% |
Q1 2023 | $107,841 | -45.6% | 34,900 | -25.5% | 0.00% | -63.6% |
Q4 2022 | $198,108 | +73.8% | 46,834 | +18.0% | 0.01% | +120.0% |
Q1 2022 | $114,000 | -17.4% | 39,700 | -12.6% | 0.01% | -44.4% |
Q4 2021 | $138,000 | -40.5% | 45,400 | +97.4% | 0.01% | -80.9% |
Q3 2020 | $232,000 | – | 23,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,300,000 | $12,636,000 | 2.61% |
AIGH Capital Management LLC | 964,590 | $9,376,000 | 1.97% |
Worth Venture Partners, LLC | 226,758 | $2,204,000 | 1.07% |
Camber Capital Management LP | 2,555,000 | $24,835,000 | 0.85% |
Palo Alto Investors LP | 1,392,997 | $13,540,000 | 0.77% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,769,795 | $36,642,000 | 0.77% |
GLOBEFLEX CAPITAL L P | 428,680 | $4,167,000 | 0.76% |
Zebra Capital Management LLC | 34,243 | $333,000 | 0.37% |
Sofinnova Investments, Inc. | 344,917 | $3,353,000 | 0.20% |
RICE HALL JAMES & ASSOCIATES, LLC | 605,792 | $5,888,000 | 0.19% |